Recall archive / FDA drug enforcement

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957. — FDA record D-1341-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 27, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
Reason: Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.
Classification: Class II
Recalling firm: Loud Muscle Science
Quantity: 1500 4-count tins
Agency-reported status: Terminated
Source record identifier: D-1341-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot# C07172101, Exp date: 07/2024

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The product was distributed nationwide in the USA and Canada.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: Jul 27, 2022
Recall initiation date: Jun 27, 2022
Center classification date: Aug 15, 2022
Termination date: Feb 8, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.